Management of Measles in Pediatric Patients
Children diagnosed with measles require airborne isolation precautions, vitamin A supplementation (200,000 IU for children ≥12 months, 100,000 IU for infants, given on two consecutive days), supportive care, and immediate post-exposure prophylaxis for susceptible household contacts with either MMR vaccine within 72 hours or immune globulin within 6 days of exposure.
Isolation and Infection Control
Place the child in airborne isolation immediately upon suspicion of measles. Healthcare workers must wear N-95 respirators, and the patient should remain in an airborne infection isolation room 1, 2. Isolation should continue until 4 days after rash onset to prevent transmission to other patients and healthcare personnel.
Vitamin A Supplementation
Administer vitamin A on two consecutive days 3:
- Children ≥12 months: 200,000 IU orally daily for 2 days
- Infants 6-11 months: 100,000 IU orally daily for 2 days
- Infants <6 months: 50,000 IU orally daily for 2 days
This dosing regimen reduces mortality risk in children under 2 years (RR 0.18) and pneumonia-specific mortality (RR 0.33) 3. The evidence strongly supports two doses over a single dose, as single-dose regimens showed no mortality benefit 3. Vitamin A is particularly critical in hospitalized children and those with complications 2, 4.
Supportive Care
Treatment is primarily supportive as no specific antiviral therapy is FDA-approved for measles 1, 2, 5:
- Hydration management: Monitor for dehydration from fever and decreased oral intake
- Fever control: Antipyretics as needed
- Respiratory support: Oxygen supplementation for pneumonia or respiratory distress
- Nutritional support: Maintain adequate caloric intake
- Monitor for complications: Watch for encephalitis (altered mental status, seizures), pneumonia (respiratory distress), and secondary bacterial infections
Critical care admission may be necessary for severe respiratory complications, encephalitis, or hemodynamic instability 2.
Post-Exposure Prophylaxis for Household Contacts
Determine Immunity Status First
Contacts are considered immune if they have 6:
- Documentation of 2 doses of MMR vaccine (first dose ≥12 months of age)
- Laboratory evidence of measles immunity
- Born before 1957 (generally presumed immune)
For Susceptible Contacts (Non-Immune):
Within 72 hours of exposure 6:
- MMR vaccine is the preferred option for contacts ≥6 months old (except pregnant women and immunocompromised individuals)
- Infants vaccinated before 12 months must be revaccinated with 2 doses after their first birthday, separated by ≥28 days
Within 6 days of exposure (if MMR not given or contraindicated) 6:
- Immune globulin (IG) at 0.25 mL/kg body weight (maximum 15 mL) for:
- Infants ≤12 months
- Pregnant women
- Immunocompromised persons (use 0.5 mL/kg, maximum 15 mL)
- Other susceptible household contacts who cannot receive vaccine
Critical caveat: If a mother is diagnosed with measles, all unvaccinated children in the household should receive IG regardless of age 6. After IG administration, MMR vaccine should be given 5-6 months later (once the child is ≥12 months old) to establish long-term immunity 6.
Special Populations:
Immunocompromised contacts: Higher IG dose (0.5 mL/kg) and MMR vaccine is contraindicated 6
Pregnant women: IG only; MMR vaccine is contraindicated 6
Healthcare workers with uncertain immunity: Should receive MMR vaccine or be tested for immunity 7
Common Pitfalls to Avoid
- Do not use single-dose vitamin A: Evidence shows no mortality benefit with single dosing 3
- Do not delay isolation: Measles is airborne and highly contagious; standard droplet precautions are insufficient 1, 2
- Do not give IG to control outbreaks: IG is only for individual household contacts, not outbreak control 6
- Do not assume infants <6 months are protected: If the mother has measles, these infants need IG despite typically having maternal antibodies 6
- Remember the timing window: MMR effectiveness drops significantly after 72 hours; IG must be given within 6 days 6